OneThree Biotech

About:

OneThree Biotech redesigns drug discovery with biology-driven artificial intelligence.

Top Investors: Primary Venture Partners, Meridian Street Capital

Description:

OneThree Biotech redesigns drug discovery with biology-driven artificial intelligence to uncover new insights. Its platform predicts new potential therapeutics and pinpoints the mechanisms driving efficacy. It also integrates over 30 types of chemical, biological, and clinical data for each task that leads to a significant increase in accuracy, interpretability, and chance of clinical success. OneThree Biotech was founded in 2018 and is headquartered in New York, United States.

Total Funding Amount:

$2.5M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

New York, New York, United States

Founded Date:

2018-01-01

Contact Email:

info(AT)onethree.bio

Founders:

Bradlay Pryde, Coryandar Gilvary, Neel S. Madhukar, Olivier Elemento

Number of Employees:

1-10

Last Funding Date:

2020-03-26

IPO Status:

Private

Industries: